Methods for modulating cell pluripotency and self-renewal property
AssigneeMemorial Sloan Kettering Cancer Center
InventorsLydia W.S. Finley, Paige K, Arnold, Benjamin T. Jackson
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods for modulating (e.g., maintaining) pluripotency and self-renewal property of cells (e.g., stem cells) by blocking the non-canonical tricarboxylic acid (TCA) cycle (e.g. using an inhibitor of ATP citrate lyase (ACL) or acetate), and kits and compositions relating thereto.
Claims21
-48. (canceled)
A method for maintaining pluripotency of cells, comprising blocking non-canonical tricarboxylic acid (TCA) cycle of the cells, wherein the blocking comprises contacting the cells with an ATP citrate lyase (ACL) inhibitor.
A method for maintaining self-renewal property of cells, comprising blocking non-canonical tricarboxylic acid (TCA) cycle of the cells, wherein the blocking comprises contacting the cells with an ATP citrate lyase (ACL) inhibitor.
A plurality of cells, wherein pluripotency of the cells is maintained, after blocking the non-canonical tricarboxylic acid (TCA) cycle of the cells, wherein blocking the non-canonical TCA cycle comprises contacting the cells with an ATP citrate lyase (ACL) inhibitor.
A plurality of cells, wherein self-renewal property of the cells is maintained, after blocking the non-canonical tricarboxylic acid (TCA) cycle of the cells, wherein blocking the non-canonical TCA cycle comprises contacting the cells with an ATP citrate lyase (ACL) inhibitor.
Dependencies are inferred from the claim text.